Saturday 17 October 2026
Export HCTI’s income statement to Excel — free account
Healthcare Triangle, Inc.
HCTI Healthcare Health Information Services
Healthcare Triangle, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.9 million, up 18.8% from fiscal 2024. In the quarter to June 2026, revenue grew 158.4%, EPS grew 95.5%, free cash flow grew 67.5% and total debt rose 2,749.9%, each against the same quarter a year earlier.
0.40
0.02
−4.76%
Follow HCTI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.90 | 0.17 | 0.13 | 0.20 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(7.82) | (0.34) | (0.36) | (6.10) | |
P/B ratio |
9.07 | 0.94 | 0.09 | 0.21 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.97 | 0.46 | 0.39 | 0.58 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(1.19) | (0.38) | (0.44) | (0.94) | |
EV/FCF |
(1.06) | (0.35) | (0.41) | (0.85) | |
Quick Ratio |
1.04 | 0.76 | 0.60 | 0.51 | |
Current Ratio |
2.03 | 1.03 | 0.90 | 0.60 | |
Net Debt/EBITDA |
0.04 | (0.82) | (1.92) | (2.80) | |
Debt/Assets |
11.06% | 47.22% | 12.12% | 16.06% | |
Debt/Equity |
0.18 | 1.08 | 0.18 | 0.24 | |
Asset Turnover |
1.39 | 1.12 | 0.44 | 0.58 | |
Operating CF/Net income |
0.79 | 1.52 | 1.11 | 0.19 | |
Capex/Depreciation |
(20.41) | (0.34) | (0.03) | (0.05) | |
Interest Coverage |
(80.97) | (43.97) | (42.62) | (45.74) | |
Research and Development Expense of Revenue |
1.69% | 8.85% | 0.86% | 0.55% | |
Selling, General and Administrative Expense of Revenue |
89.05% | 125.64% | 50.70% | 60.27% | |
Intangible Assets out of Total Assets |
0.43 | 0.25 | 0.73 | 0.78 | |
Share Based Compensation of Revenue |
11.89% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
0.24 | 0.15 | (3.42) | (2.93) | |
Graham Number |
0.00 | 0.00 | 1,262.84 | 682.34 | |
Earnings Yield |
(3,832.64%) | (309.62%) | 89,981.60% | 135,562.21% | |
Free Cash Flow Yield |
(100.77%) | (767.01%) | (772.88%) | (346.06%) | |
Revenue per Share |
47.02 | 50.73 | 10.59 | 3.28 | |
Operating CF per Share |
(20.18) | (110.40) | (7.37) | (0.30) | |
Capex per Share |
(17.33) | (3.47) | (0.02) | (0.01) | |
Free Cash Flow per Share |
(37.51) | (113.88) | (7.40) | (0.31) | |
Cash per Share |
21.95 | 123.18 | 4.63 | 0.68 | |
Shareholders Equity per Share |
117.60 | 160.65 | 56.60 | 17.50 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
117.60 | 160.65 | 56.60 | 17.50 | |
Free Cash Flow |
(2.78) | (7.05) | (6.89) | (0.86) | |
Working Capital |
4.03 | 0.36 | (2.10) | (6.34) | |
Capital Expenditures |
(1.29) | (0.21) | (0.02) | (0.02) | |
Net Current Asset Value |
2.83 | 0.36 | (8.57) | (14.89) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.37 | 0.07 | 0.00 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
2.03 | 1.59 | 5.14 | 4.02 | |
Average Payables |
1.80 | 1.64 | 2.45 | 1.64 | |
Average Assets |
9.30 | 12.35 | 45.97 | 44.10 | |
Average Common Equity |
(0.26) | (5.02) | 14.20 | 13.22 |
Columns are period end dates